DE60133581D1 - Von lactobacillus casei ke01 stamm abgeleitete probiotische verbindungen - Google Patents

Von lactobacillus casei ke01 stamm abgeleitete probiotische verbindungen

Info

Publication number
DE60133581D1
DE60133581D1 DE60133581T DE60133581T DE60133581D1 DE 60133581 D1 DE60133581 D1 DE 60133581D1 DE 60133581 T DE60133581 T DE 60133581T DE 60133581 T DE60133581 T DE 60133581T DE 60133581 D1 DE60133581 D1 DE 60133581D1
Authority
DE
Germany
Prior art keywords
lactobacillus casei
stem
compounds derived
probiotic compositions
probiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60133581T
Other languages
English (en)
Other versions
DE60133581T2 (de
Inventor
A Satyanarayan Naidu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PROBIO HEALTH
Original Assignee
PROBIO HEALTH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PROBIO HEALTH filed Critical PROBIO HEALTH
Publication of DE60133581D1 publication Critical patent/DE60133581D1/de
Application granted granted Critical
Publication of DE60133581T2 publication Critical patent/DE60133581T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/125—Casei
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/856—Lactobacillus casei

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Physiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60133581T 2000-12-18 2001-12-17 Von lactobacillus casei ke01 stamm abgeleitete probiotische verbindungen Expired - Lifetime DE60133581T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25652800P 2000-12-18 2000-12-18
US256528P 2000-12-18
PCT/US2001/048707 WO2002058712A2 (en) 2000-12-18 2001-12-17 Probiotic compounds derived from lactobacillus casei strain ke01

Publications (2)

Publication Number Publication Date
DE60133581D1 true DE60133581D1 (de) 2008-05-21
DE60133581T2 DE60133581T2 (de) 2009-06-04

Family

ID=22972567

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60133581T Expired - Lifetime DE60133581T2 (de) 2000-12-18 2001-12-17 Von lactobacillus casei ke01 stamm abgeleitete probiotische verbindungen

Country Status (13)

Country Link
US (1) US6797266B2 (de)
EP (1) EP1345613B1 (de)
JP (2) JP5186077B2 (de)
KR (1) KR20040018319A (de)
AT (1) ATE391509T1 (de)
AU (1) AU2002246679B2 (de)
BR (1) BR0116349A (de)
CA (1) CA2442602A1 (de)
DE (1) DE60133581T2 (de)
IL (1) IL156490A0 (de)
MX (1) MXPA03005465A (de)
NZ (1) NZ526443A (de)
WO (1) WO2002058712A2 (de)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029702B2 (en) * 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
US7998470B2 (en) 1999-04-30 2011-08-16 Kibow Biotech, Inc. Compositions and methods improving renal function
US7026160B2 (en) * 1999-04-30 2006-04-11 Kibow Biotech, Inc. Oral bacteriotherapy compositions and methods
US20040161422A1 (en) * 1999-04-30 2004-08-19 Natarajan Ranganathan Nutritional compositions comprising probiotics
US20040197352A1 (en) * 1999-04-30 2004-10-07 Natarajan Ranganathan Methods of improving or augmenting kidney function
SE0003100D0 (sv) * 2000-09-01 2000-09-01 Probi Ab New strains
US7214370B2 (en) 2000-12-18 2007-05-08 Probiohealth, Llc Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
EP1345613B1 (de) * 2000-12-18 2008-04-09 Probio Health Von lactobacillus casei ke01 stamm abgeleitete probiotische verbindungen
PE20030283A1 (es) * 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de lactobacillus casei
US20030175305A1 (en) * 2002-01-08 2003-09-18 Garner Bryan E. Compositions and methods for inhibiting pathogenic growth
US20040028665A1 (en) 2002-01-08 2004-02-12 Garner Bryan E. Compositions and methods for inhibiting pathogenic growth
US7182943B2 (en) * 2002-05-15 2007-02-27 UNIVERSITé LAVAL Method and system for modulation of microbial cell characteristics
GB0212975D0 (en) 2002-06-06 2002-07-17 Mars Uk Ltd Mammalian animal composition
US7323166B2 (en) 2002-06-19 2008-01-29 Board Of Regents University Of Nebraska Lactic acid bacteria cultures that inhibit food-borne pathogens
CA2549115C (en) * 2002-09-26 2013-07-16 Vita-Herb Nutriceuticals, Inc. Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
US20040241150A1 (en) * 2002-12-19 2004-12-02 Hargis Billy M. Defined competitive exclusion cultures for food borne pathogens
WO2004062388A1 (en) * 2003-01-06 2004-07-29 Nutrition Physiology Corporation Compositions and methods for reducing the pathogen content of meat and meat products
WO2004104175A2 (en) * 2003-05-14 2004-12-02 University Of Georgia Research Foundation, Inc. Probiotic bacteria and methods
ATE504645T1 (de) * 2003-06-23 2011-04-15 Univ North Carolina State Für fructooligosaccharid-nutzende verbindungen codierende nukleinsäuren aus lactobacillus acidophilus und verwendungen davon
WO2005000034A2 (en) * 2003-06-23 2005-01-06 Agtech Products, Inc. Lactic bacteria and its use in direct-fed microbials
CA2540467C (en) * 2003-09-30 2013-11-12 Kibow Biotech, Inc. Compositions and methods for augmenting kidney function
US20050100559A1 (en) * 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
MY143693A (en) 2004-03-24 2011-06-30 Nestec Sa Shelf stable product wih living micro-organisms
US20080126195A1 (en) * 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
EP2270131A1 (de) 2005-05-31 2011-01-05 The Iams Company Probiotische Katzen-Laktobazillen
AU2006253007B2 (en) 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
PT1962873E (pt) * 2005-12-14 2013-08-29 Oxthera Inc Composições farmacêuticas compreendendo bactérias redutoras de oxalato
ES2362897T3 (es) 2005-12-16 2011-07-14 Oxthera, Inc. Composiciones y métodos para reducción del oxalato.
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
ES2470340T3 (es) 2005-12-28 2014-06-23 Advanced Bionutrition Corporation Vehículo de administración para bacterias probi�ticas que comprende una matriz seca de polisac�ridos, sac�ridos y polioles en forma vítrea
CA2673120C (en) * 2006-12-18 2012-08-07 Advanced Bionutrition Corporation A dry food product containing live probiotic
PL2124966T3 (pl) 2007-02-01 2016-01-29 Iams Europe B V Sposób zmniejszania reakcji zapalnej i stresu u ssaków za pomocą antymetabolitów glukozy, awokado lub ekstraktów awokado
RU2468807C2 (ru) * 2007-02-28 2012-12-10 Мед Джонсон Нутришен Компани Детское питание, содержащее инактивированный пробиотик
TW200904340A (en) 2007-05-11 2009-02-01 Mannatech Inc Processing of natural polysaccharides by selected non-pathogenic microorganisms and methods of making and using the same
JP5259253B2 (ja) * 2008-05-19 2013-08-07 森下仁丹株式会社 シームレスカプセル
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
WO2010008491A2 (en) * 2008-06-25 2010-01-21 Ritter Natural Sciences, Llc Lactose compositions with decreased lactose content
JP2009102324A (ja) * 2008-11-27 2009-05-14 Morishita Jintan Kk 乳酸菌含有血中アンモニア低減剤
FR2939045B1 (fr) * 2008-12-02 2010-12-31 Daniel Sincholle Compositions pharmaceutiques et nutritionnelles et methode utile pour prevenir et traiter l'inflammation colique et l'endotoxemie metabolique
CA2984935C (en) 2009-02-24 2021-01-12 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
ES2908047T3 (es) 2009-03-27 2022-04-27 Intervet Int Bv Vacunas en micropartículas para la vacunación oral o nasal y el refuerzo de animales incluidos los peces
NZ597053A (en) 2009-05-26 2014-02-28 Advanced Bionutrition Corp Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
EP2529004B1 (de) 2010-01-28 2017-06-07 Advanced Bionutrition Corporation Trockenglaszusammensetzung mit einem bioaktiven material
US7888062B1 (en) 2010-02-01 2011-02-15 Microbios, Inc. Process and composition for the manufacture of a microbial-based product
US8445226B2 (en) 2010-02-01 2013-05-21 Microbios, Inc. Process and composition for the manufacture of a microbial-based product
EP3202406A1 (de) 2010-04-28 2017-08-09 Ritter Pharmaceuticals, Inc. Präbiotische formulierungen und deren verwendungen
IT1405395B1 (it) * 2010-08-05 2014-01-10 Proge Farm Srl Composizioni di probiotici e oli e loro uso.
CN103140145B (zh) 2010-08-13 2014-08-20 高级生物营养公司 用于生物材料的干的贮存稳定用组合物
WO2012044984A1 (en) 2010-09-30 2012-04-05 The Board Of Trustees Of The University Of Arkansas Methods of selecting and using therapeutic and prophylactic probiotic cultures to reduce bacterial pathogen loads
CL2010001628A1 (es) 2010-12-30 2011-04-25 Univerisidad De Concepcion Alimento probiotico para peces que comprende lactobacillus plantarum, lactococcus lactis lactis, pediococcus acidilactic, pediococcus damnosus y/o plantarum, harina y descartes de pescado, poroto de soya, harina de trigo, aceite de pescado y almidon de maiz; y proceso de elaboracion de dicho alimento.
KR101166798B1 (ko) * 2011-12-19 2012-07-26 김대현 락토바실러스 애시도필러스 엘비의 사균을 포함하는 알레르기 질환의 치료 또는 예방용 의약 조성물
KR20170021350A (ko) 2014-07-01 2017-02-27 프로비 유에스에이, 인코포레이티드 이층 이중 방출 프로바이오틱 정제
WO2016025448A2 (en) * 2014-08-13 2016-02-18 Akeso Biomedical, Inc. Antimicrobial compounds and compositions, and uses thereof
US20170333494A1 (en) * 2014-11-10 2017-11-23 Glaxosmithkline Intellectual Property Development Limited Probiotic therapeutic applications
EP3229595B1 (de) * 2014-12-12 2021-02-03 The Regents of the University of California Reduktion von milchglykanen und deren abbauprodukten im darm von neugeborener
CA2994112C (en) 2015-07-29 2023-08-08 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
EP3334440B1 (de) 2015-08-11 2021-04-14 Akeso Biomedical, Inc. Biofilmhemmende zusammensetzungen zur verbesserung der gewichtszunahme bei nutztieren
US10653658B2 (en) 2015-08-11 2020-05-19 Akeso Biomedical, Inc. Biofilm inhibiting compositions enhancing weight gain in livestock
JPWO2017217350A1 (ja) 2016-06-13 2019-02-21 株式会社村田製作所 抗菌抗ウイルス薬、抗菌抗ウイルス部材、及び抗菌抗ウイルス薬の製造方法
US10258567B1 (en) 2016-11-17 2019-04-16 Grace Procurements Llc Vaginal probiotic products and related processes
RU2674772C1 (ru) * 2017-11-09 2018-12-13 Тарас Владимирович Герунов Способ профилактики отравлений у животных
CN110643533B (zh) * 2019-09-24 2020-11-13 扬州大学 降解油脂的干酪乳杆菌及其应用
EP4121073A1 (de) 2020-03-16 2023-01-25 Biosearch S.A. Biokomposite mit probiotika, kollagen und bakteriellem extrazellulärem polysaccharid und verwendungen davon
CN111560330B (zh) * 2020-05-12 2022-04-26 天津科技大学 一种具有免疫调节、抗炎和抗宫颈癌作用的干酪乳杆菌及应用
WO2022082027A1 (en) * 2020-10-15 2022-04-21 University Of Louisville Research Foundation, Inc. Probiotic delivery systems and methods of making and using
EP4252541A1 (de) * 2020-12-25 2023-10-04 Hayashibara Co., Ltd. Verfahren zur verbesserung der produktivität bei vieh und/oder geflügel und verfahren zur verbesserung der darmflora bei vieh und/oder geflügel
CN112625979B (zh) * 2021-01-14 2023-01-06 四川大学华西医院 一种对抗幽门螺杆菌的干酪乳杆菌及其应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2421066A1 (de) 1974-05-02 1976-03-25 Solco Basel Ag Bifidobakterien enthaltendes praeparat
US3957974A (en) 1974-11-05 1976-05-18 Seikenkai Method for deodorization of excrements
JPS52102419A (en) 1976-02-23 1977-08-27 Seikenkai Lactic acid producing bacillus preparation
US4210672A (en) 1976-04-02 1980-07-01 Seikenkai Preparation of yogurt
JPS52154590A (en) 1976-05-21 1977-12-22 Seikenkai Cultivating and preserving method of deodorising lactobucillus and liling cell preparation
JPS587297B2 (ja) 1976-05-21 1983-02-09 秦 興世 脱臭剤とその製造方法及び保存法
JPS5911177A (ja) * 1982-07-12 1984-01-20 Seikenkai 新規乳酸桿菌
JPS60149527A (ja) 1984-01-17 1985-08-07 Seikenkai 生体内脱臭剤
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US5804179A (en) * 1985-12-31 1998-09-08 Research Corporation Technologies, Inc. Lactobacillus compositions and methods for treating urinary tract infections
AU624067B2 (en) 1986-12-12 1992-06-04 Biorem C.C. Preparation suitable for use in the treatment of enteric disorders
SE469875C (sv) * 1991-07-25 1997-02-05 Probi Ab Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen
JP2506314B2 (ja) * 1993-10-27 1996-06-12 全国農業協同組合連合会 家禽・豚の敗血症の予防・治療剤及び飼料
HU220190B (hu) 1994-05-26 2001-11-28 Bracco S.P.A. Humán eredetű Lactobacillus törzsek, ilyen törzseket tartalmazó gyógyászati készítmények és alkalmazásuk
AUPM823094A0 (en) 1994-09-16 1994-10-13 Goodman Fielder Limited Probiotic compositions
WO1998011900A2 (en) 1996-09-18 1998-03-26 Sarill William J Compositions containing cobalamin and amino acids
SE511524C2 (sv) * 1997-06-02 1999-10-11 Essum Ab Lactobacillus casei rhamnosus-stam samt farmaceutisk beredning för bekämpning av patogena tarmbakterier
US5965128A (en) 1997-08-13 1999-10-12 University Of Georgia Research Foundation Inc. Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
ES2258841T3 (es) * 1998-04-01 2006-09-01 Ganeden Biotech, Inc. Procedimientos para reducir el colesterol con esporas de bacillus coagulans, sistemas y composiciones asociados.
AU1543400A (en) * 1998-12-11 2000-07-03 Urex Biotech Inc. Oral administration of lactobacillus for the treatment and prevention of urogenital infection
JP2000197469A (ja) * 1999-01-08 2000-07-18 New Food Creation Gijutsu Kenkyu Kumiai 血清脂質改善効果を有する機能性飲食品
SE523771C2 (sv) * 1999-05-21 2004-05-18 Probi Ab Sportdryck innehållande mikronäringsämnen i kombination med levande laktobaciller
EP1345613B1 (de) * 2000-12-18 2008-04-09 Probio Health Von lactobacillus casei ke01 stamm abgeleitete probiotische verbindungen

Also Published As

Publication number Publication date
JP2010195778A (ja) 2010-09-09
MXPA03005465A (es) 2004-10-14
US20020192202A1 (en) 2002-12-19
JP5186077B2 (ja) 2013-04-17
CA2442602A1 (en) 2002-08-01
WO2002058712A2 (en) 2002-08-01
WO2002058712A3 (en) 2003-06-05
ATE391509T1 (de) 2008-04-15
IL156490A0 (en) 2004-01-04
EP1345613B1 (de) 2008-04-09
EP1345613A2 (de) 2003-09-24
BR0116349A (pt) 2003-12-23
KR20040018319A (ko) 2004-03-03
AU2002246679B2 (en) 2006-11-16
JP2004525106A (ja) 2004-08-19
DE60133581T2 (de) 2009-06-04
US6797266B2 (en) 2004-09-28
NZ526443A (en) 2005-03-24

Similar Documents

Publication Publication Date Title
DE60133581D1 (de) Von lactobacillus casei ke01 stamm abgeleitete probiotische verbindungen
BR9916062A (pt) Administração oral de lactobacillus para o tratamento e prevenção de infecção urogenital
HUP0301939A2 (hu) Új probiotikumok hobbiállat-eledel kompozíciókhoz
DE60205646D1 (de) Einen lactobacillus-stamm enthaltende zusammensetzung und verwendungen davon
HK1079104A1 (en) Orally administrable composition to human for the photoprotection of the skin
DE602004006133D1 (de) Neue galactooligosaccharidzusammensetzung und herstellung davon
FI20001460A (fi) Probiootit atooppisten sairauksien primaariseen ehkäisyyn
EA200101262A1 (ru) Диетическая или фармацевтическая композиция для применения в целях профилактики или лечения гипероксалурии
MXPA04008182A (es) Composicion fotoprotectora para la piel, oralmente adminstrable.
BRPI0418986A (pt) cepas bacterianas bifidobacterium produtoras de ácido fólico, formulações e seus usos
BRPI0417826A (pt) bifidobactéria pseudolongum probiótica canina
WO2005060707A3 (en) Methods of use of probiotic lactobacilli for companion animals
DK1699474T4 (da) Probiotiske tabletformuleringer
EA200201248A1 (ru) Применение lactobacillus casei в иммуностимуляторных пептидах
EA200702254A1 (ru) Вакцинная композиция, содержащая в-субъединицу термолабильного токсина e.coli и антиген и адъювант
UA94056C2 (uk) Застосування специфічних молочнокислих бактерій для одержання імуномодулюючих композицій
WO2003039260A3 (en) PROBIOTIC COMPOSITIONS
DE69927930D1 (de) Zusammensetzung geeignet als Nahrungsmittelzusatz und zur Anwendung bei Darmerkrankungen sowie bei veränderter Darmflora
ATE421990T1 (de) Zusammensetzung zur förderung der vermehrung von lactobacillus casei subsp. casei
NO20014788D0 (no) En sammensetning for senkning av konsentrasjonen av sykdomsfremkallende tarmpeptider
AU2003206926A8 (en) Cultivation method for micro-organisms and bioreactor
RU2001135343A (ru) Штамм бактерий Bifidobacterium longum 58B для приготовления биологически активных добавок, регулирующих микрофлору кишечника у детей раннего возраста
RU2002103078A (ru) Способ профилактики диарейных болезней новорожденных телят и поросят
MX2022015957A (es) Probioticos de origen porcino que promueven la salud y el rendimiento del crecimiento en cerdos.
WO2001051649A3 (en) Identification of virulence determinants

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: STROHSCHAENK UND KOLLEGEN, 85521 OTTOBRUNN